John Raymond Murphy - Significant Ownership

Signature - Title
John Raymond Murphy - John Raymond Murphy
Location
Springfield, MO
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by John Raymond Murphy.

Significant Ownership of John Raymond Murphy

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVKD Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share 2.96% $928K 53.2K John Raymond Murphy Dec 31, 2024

Schedules 13D/G Reported by John Raymond Murphy:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.